Get the app!
Back to Companies

Foghorn Therapeutics Inc.

FHTXNasdaqCIK: 0001822462

Foghorn Therapeutics Inc. (FHTX) shows 13 recent insider filings from 13 insiders, with no open-market buying or selling. Maynard Ryan D is the most active by dollar volume, and the single largest transaction was $2.3M by Maynard Ryan D. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$6.3M
Purchases
$0
Sales
$0
Unique Insiders
13

Recent Insider Trades

13 loaded
Jun 25FHTX
Foghorn Therapeutics Inc.
Mendelsohn MichaelInsiderAward$114.2K
Jun 25FHTX
Foghorn Therapeutics Inc.
Lynch Thomas J. Jr.InsiderAward$114.2K
Jun 25FHTX
Foghorn Therapeutics Inc.
SMITH IAN FInsiderAward$114.2K
Jun 25FHTX
Foghorn Therapeutics Inc.
Gallagher NeilInsiderAward$114.2K
Jun 25FHTX
Foghorn Therapeutics Inc.
Duty StuartInsiderAward$114.2K
Jun 25FHTX
Foghorn Therapeutics Inc.
PARSHALL B LYNNEInsiderAward$114.2K
Jun 25FHTX
Foghorn Therapeutics Inc.
Biller ScottInsiderAward$114.2K
Jun 25FHTX
Foghorn Therapeutics Inc.
GILL SIMBAInsiderAward$114.2K
Jun 25FHTX
Foghorn Therapeutics Inc.
Cole Douglas G.InsiderAward$114.2K
Feb 24FHTX
Foghorn Therapeutics Inc.
Maynard Ryan DInsiderAward$2.3M
Feb 2FHTX
Foghorn Therapeutics Inc.
LaCascia MichaelInsiderAward$1.7M
Feb 2FHTX
Foghorn Therapeutics Inc.
Costa CarlosInsiderAward$1.3M
Jan 15FHTX
Foghorn Therapeutics Inc.
Flagship Pioneering, LLCInsiderAward$224

13 filings